TrialPath
Recruiting

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT07680764 · Bristol-Myers Squibb
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Phase 2, Randomized, Open-label, Study Assessing the Safety, Tolerability and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
About this study
The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDCT) versus Pumitamig and PDCT as first-line treatment for participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Eligibility criteria
Inclusion Criteria * Participants must have histologically confirmed diagnosis of stage IV non-small cell lung cancer (NSCLC) (squamous or non-squamous) or recurrent unresectable disease per the American joint committee on cancer (AJCC) Staging System 9th edition. * Participants must have no prior systemic anti-cancer therapy given as primary therapy for advanced or metastatic disease. * Tumor tissue (fresh or archival) obtained within 5 months of enrollment (signing of informed consent) for each participant must be submitted by the site. * Participants must have an Eastern Cooperative Oncology Group Performance Status of 0 or 1. * Participants must have measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1. Exclusion Criteria * Participants must not have any documented actionable genomic alterations (AGAs) for which first line approved targeted therapies are indicated. * Participants must not have prior treatment with immuno-oncology therapies. * Participants must not have untreated central nervous system (CNS) metastases. * Other protocol-defined Inclusion/Exclusion criteria apply.
Study design
Enrollment target: 160 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-09-10
Estimated completion: 2030-09-15
Last updated: 2026-10-23
Interventions
Drug: PumitamigDrug: ImzokitugDrug: PemetrexedDrug: CisplatinDrug: CarboplatinDrug: Paclitaxel
Primary outcomes
  • • Objective response rate (ORR) by investigator (per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1) (Up to approximately 4 years)
Sponsor
Bristol-Myers Squibb · industry
Contacts & investigators
ContactBMS Clinical Trials Contact Center www.BMSClinicalTrials.com · contact · Clinical.Trials@bms.com · 855-907-3286
ContactFirst line of the email MUST contain NCT # and Site #. · contact
InvestigatorBristol-Myers Squibb · study_director, Bristol-Myers Squibb
All locations (74)
Local Institution - 0183Not Yet Recruiting
Washington D.C., District of Columbia, United States
University Cancer & Blood Center, LLCRecruiting
Athens, Georgia, United States
Baptist Health LexingtonRecruiting
Lexington, Kentucky, United States
Baptist Health HamburgRecruiting
Lexington, Kentucky, United States
Local Institution - 0123Not Yet Recruiting
Baltimore, Maryland, United States
Hattiesburg ClinicRecruiting
Hattiesburg, Mississippi, United States
Nebraska Cancer SpecialistsRecruiting
Grand Island, Nebraska, United States
Oncology Hematology West PCRecruiting
Omaha, Nebraska, United States
Local Institution - 0080Not Yet Recruiting
New York, New York, United States
Local Institution - 0176Not Yet Recruiting
Columbus, Ohio, United States
Local Institution - 0095Not Yet Recruiting
Houston, Texas, United States
Local Institution - 0135Not Yet Recruiting
Madison, Wisconsin, United States
Sanatorio Parque RosarioRecruiting
Rosario, Santa Fe Province, Argentina
Instituto Medico Especializado Alexander FlemingRecruiting
Buenos Aires, Argentina
Clinica Viedma S.A.Recruiting
Viedma, Argentina
Gosford HospitalRecruiting
Gosford, New South Wales, Australia
Local Institution - 0134Not Yet Recruiting
Westmead, New South Wales, Australia
Local Institution - 0167Not Yet Recruiting
Greenslopes, Queensland, Australia
Local Institution - 0100Not Yet Recruiting
Heidelberg, Victoria, Australia
St. John of God Murdoch HospitalRecruiting
Perth, Western Australia, Australia
Local Institution - 0003Not Yet Recruiting
Natal/RN, Rio Grande do Norte, Brazil
Local Institution - 0006Not Yet Recruiting
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution - 0005Not Yet Recruiting
Barretos, São Paulo, Brazil
Local Institution - 0001Not Yet Recruiting
São Paulo, Brazil
Orlandi OncologiaRecruiting
Santiago, Santiago Metropolitan, Chile
BradfordhillRecruiting
Santiago, Santiago Metropolitan, Chile
Oncocentro ApysRecruiting
Viña del Mar, Valparaiso, Chile
Local Institution - 0038Not Yet Recruiting
Beijing, Beijing Municipality, China
Local Institution - 0138Not Yet Recruiting
Fuzhou, Fujian, China
Local Institution - 0050Not Yet Recruiting
Wuhan, Hubei, China
Local Institution - 0147Not Yet Recruiting
Nanjing, Jiangsu, China
Local Institution - 0140Not Yet Recruiting
Shanghai, Shanghai Municipality, China
Local Institution - 0169Not Yet Recruiting
Shanghai, Shanghai Municipality, China
Local Institution - 0144Not Yet Recruiting
Chengdu, Sichuan, China
Local Institution - 0137Not Yet Recruiting
Hangzhou, Zhejiang, China
Local Institution - 0131Not Yet Recruiting
Nice, Alpes-Maritimes, France
Hôpital Arnaud de Villeneuve - CHU MontpellierRecruiting
Montpellier, Hérault, France
Local Institution - 0087Not Yet Recruiting
Montpellier, Languedoc-Roussillon, France
Local Institution - 0119Not Yet Recruiting
Villejuif, Val-de-Marne, France
Local Institution - 0047Not Yet Recruiting
Grenoble, France
Assistance Publique Hôpitaux de Marseille - Hôpital NordRecruiting
Marseille, France
Hopitaux Universitaires Paris Centre-Hopital CochinRecruiting
Paris, France
Local Institution - 0085Not Yet Recruiting
Saint-Herblain, France
Local Institution - 0019Not Yet Recruiting
Paris, Île-de-France Region, France
Robert Bosch KrankenhausRecruiting
Stuttgart, Baden-Wurttemberg, Germany
Local Institution - 0156Not Yet Recruiting
Marburg, Hesse, Germany
Local Institution - 0152Not Yet Recruiting
Homburg, Saarland, Germany
Klinikum Köln-MerheimRecruiting
Cologne, Germany
Christliches Klinikum Halle (Saale) GmbHRecruiting
Halle, Germany
Universitatsklinikum FrankfurtRecruiting
Hessen, Germany
Local Institution - 0148Not Yet Recruiting
Bergamo, BG, Italy
Humanitas Istituto Clinico CataneseRecruiting
Misterbianco, Catania, Italy
Local Institution - 0043Not Yet Recruiting
Bari, Italy
Local Institution - 0159Not Yet Recruiting
Milan, Italy
Local Institution - 0014Not Yet Recruiting
Ravenna, Italy
Local Institution - 0011Not Yet Recruiting
Rozzano (MI), Italy
Amethyst Radiotherapy Center-Oncologie MedicalaRecruiting
Florești, Cluj, Romania
Institutul Oncologic "Prof. Dr. Alexandru Trestioreanu" Bucuresti (IOB)Recruiting
Bucharest, Romania
Institutul Oncologic ClujRecruiting
Cluj-Napoca, Romania
Centrul de Oncologie Sf. Nectarie SRLRecruiting
Craiova, Romania
Victoria Hospital (Centrul de oncologie Euroclinic SRL) (Centrul De Oncologie Medicala) (Euroclinic Onchology Center)Recruiting
Iași, Romania
Institutul Regional de Oncologie IasiRecruiting
Iași, Romania
OncohelpRecruiting
Timisoara, Timis, Romania
Local Institution - 0132Not Yet Recruiting
Badalona, Barcelona, Spain
Local Institution - 0162Not Yet Recruiting
Seville, Seville, Spain
Hospital Universitari Vall D'HebronRecruiting
Barcelona, Spain
Hospital de la Santa Creu i Sant PauRecruiting
Barcelona, Spain
Local Institution - 0163Not Yet Recruiting
Barcelona, Spain
Local Institution - 0041Withdrawn
Madrid, Spain
Local Institution - 0010Not Yet Recruiting
Majadahonda, Spain
Hospital Carlos Haya De MalagaRecruiting
Málaga, Spain
Local Institution - 0182Not Yet Recruiting
Birmingham, BIR, United Kingdom
Local Institution - 0035Not Yet Recruiting
London, Greater London, United Kingdom
The Royal Surrey County Hospital NHS Foundation TrustRecruiting
Guildford, United Kingdom